The biosimilar market is getting bigger, faster, and honestly a little chaotic. Patent cliffs are coming one after another, biologics are losing exclusivity across the world, and every pharma company wants a piece of the action.
Discover the latest trends in drug discovery and development for 2026, including AI-driven research, advanced clinical trial technologies, precision medicine innovations, and emerging pharma strategies shaping the future of healthcare.
Bottom line is, 2026 will is going to be one of the most important years for healthcare sector. So let’s dive in, and get a better look at what next year have up it’s sleeves.
Explore how Phase I drug formulations transition from lab research to human testing, shaping the foundation for safe and effective clinical development.
The global herbal medicine market is booming, and at its heart lies Traditional Chinese Medicine (TCM).
Antimicrobial resistance (AMR) is getting scary. Experts say that by 2050, it could cause 10 million deaths every year if we don’t act.
Generics and biosimilars both make drugs cheaper, but they behave very differently after a patent dies.
For pharma leaders, investors, and business development teams, these five years represent both risk and opportunity on a historic scale.
Here’s what that means: traditional anticoagulants—like warfarin and LMWHs—still form the backbone of hospital and community care
Companies have realized the era of innovation and advance drug developments is around the corner. One of the key areas that is witnessing a surge is monoclonal antibodies.
13 December 2025
4 December 2025
20 November 2025
13 November 2025
11 October 2025
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com